Bilateral Lateral Rectus Recession Versus Bilateral Primary Medial Rectus Resection in Intermittent Exotropia

October 18, 2024 updated by: Ahmed Awadein, Cairo University

Comparison Between Bilateral Lateral Rectus Recession and Bilateral Primary Medial Rectus Resection in Basic Type Intermittent Exotropia

The goal of this clinical trial is to compare the efficacy of bilateral lateral rectus recession and bilateral primary medial rectus resection in basic type intermittent exotropia

Participants will be randomized into two groups: bilateral lateral rectus (BLR) recession and bilateral medial rectus (BMR) resection groups then followed up in the clinic for 6 months to compare motor alignment and sensory functions

Study Overview

Status

Active, not recruiting

Detailed Description

Study location: Cairo university hospitals

Methodology:

Patients with basic type intermittent exotropia who are indicated to undergo surgical intervention will be grouped into two groups one group will undergo bilateral lateral rectus recession and the other will undergo bilateral medial rectus resection.

  • Preoperatively, all patients will be subjected to:

    1. A detailed history taking including presence of asthenopia, monocular closure, disfigurement or diplopia. The previous use of glasses for optical correction, use of minus lenses, or prior part time occlusion will be documented.
    2. A detailed ophthalmological examination; including uncorrected and best corrected visual acuity whenever possible, cycloplegic refraction, anterior segment examination and dilated fundus examination.
    3. Motor Evaluation:

      • Ductions and versions will be done to assess the ocular motility in 9 positions of gaze.
      • The angle of deviation will be measured by the alternate prism cover test for both distance (6 meters) and near (33 cm) , with and without glasses.
      • The angles of misalignment will also be measured in side gazes and in straight up and down gaze whenever possible.
      • In patients with near-far disparity, the angle of deviation will be measured again after patching one eye for 30 minutes, as well as after putting +3 D lenses in front of each eye.

      Patients with near-far disparity >10 prism diopters (PD) will not be included

    4. Sensory Evaluation:

      Worth 4 dot test and stereopsis using Random dot test (when possible) The control of exotropia will be assessed using both the newcastle control score

      Patients will be randomly assigned to either surgery using simple randomization by random number generator

  • Intervention:

    • One group will undergo bilateral lateral rectus recession and the other will undergo bilateral medial rectus resection according to the standard tables.
    • All cases will be done under general anaesthesia.
    • Both surgeries take about 30 minutes.
    • Postoperative treatment combined tobramycin 0.3% and dexamethasone 0.1% eye drops 3 times daily and the same combination eye ointment at night for 3 weeks.
    • Postoperative follow up will be 1 week, 6 weeks, 3 months and 6 months (minimum follow up)
  • Postoperative assessment:

    • Extraocular movement in lateral gazes will be examined for comitance
    • Alignment in the primary position will be assessed and any deviation will be measured using alternate prism cover test
    • Palpebral fissure height will be measured
    • Worth 4 dot test and stereopsis will be assessed (when possible)

      • In cases of failure either over correction or under correction reoperation will be performed after 3 months of the initial surgery.
  • Sample size

We are planning a study of the difference in the postoperative angle between the 2 surgical techniques. Assuming a mean difference of 5 PD with a standard deviation of 5 PD, an alpha error of 0.05 and a power of study of 0.8, a total of 17 subjects were found to be needed in each group. Assuming a drop-out rate of 20%, a sample of 20 subjects will be targeted in each group.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11562
        • Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with basic type intermittent exotropia
  • Measurable angle 25-40 prism diopters

Exclusion Criteria:

  • Restrictive or paralytic deviation or if forced duction test is positive on horizontal muscles
  • Incomitant deviation, vertical or oblique muscles surgery and significant A or V pattern
  • Previous strabismus, orbital or buckle surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: BMR resection
Bilateral medial rectus muscle resection

Lid speculum will be applied. Fornix conjunctival incision will be used to expose medial rectus muscle. Area that will be resected will be marked using calipers. Double-armed polyglactin 910 suture (6/0 Vicryl) will be used in securing the muscle.

The muscle then excised anterior to the sutures and the stump cut flush to the sclera.

The muscle will be sutured again to the original insertion by scleral sutures which will be tied together.

Conjunctiva will be closed using polyglactin 910 suture (6/0 Vicryl).

Active Comparator: BLR recession
Bilateral lateral rectus muscle recession

Lid speculum will be applied. Fornix conjunctival incision will be used to expose lateral rectus muscle. Double-armed polyglactin 910 suture (6/0 Vicryl) will be used in securing the muscle close to the insertion.

The muscle will then be cut anterior to the sutures flush with the sclera. Calipers will used to mark the new insertion on sclera measured from the stump. The muscle will be sutured again to the new insertion by scleral sutures, which will be tied together.

Conjunctiva will be closed using polyglactin 910 suture (6/0 Vicryl).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor alignment in primary position
Time Frame: 12 months
Success rate defined as orthophoria between exotropia/phoria ≤ to 8 prism diopters & esotropia/phoria ≤ 4 prism diopters
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Palpebral fissure height
Time Frame: 12 months
Change in palpebral fissure height in mm
12 months
Lateral gaze comitance/incomitance
Time Frame: 12 months
Difference between angles of deviation in right gaze, primary position, and left gaze
12 months
Stereopsis
Time Frame: 12 months
Change in stereoacuity in log seconds of arc
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Yehia Salah Eldeen Mostafa, MD, Cairo University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2023

Primary Completion (Estimated)

November 1, 2024

Study Completion (Estimated)

November 1, 2024

Study Registration Dates

First Submitted

October 18, 2024

First Submitted That Met QC Criteria

October 18, 2024

First Posted (Actual)

October 21, 2024

Study Record Updates

Last Update Posted (Actual)

October 21, 2024

Last Update Submitted That Met QC Criteria

October 18, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intermittent Exotropia

Clinical Trials on BMR resection

Subscribe